United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
26.51%
Price
14.07.26
€461.00
Summary
This prediction is currently active. The prediction currently has a performance of 26.51%. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.693% | -1.693% |
| iShares Core DAX® | -3.173% | 1.229% |
| iShares Nasdaq 100 | -1.006% | 0.381% |
| iShares Nikkei 225® | -3.600% | 1.005% |
| iShares S&P 500 | 0.214% | 2.924% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€493.50
07.07.26
07.07.26
€615.51
07.07.27
07.07.27
-6.59%
14.07.26
14.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
-5.03%
14.07.26
14.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
7.99%
14.07.26
14.07.26